Mosquitos are the deadliest of all creatures, so scientists are trying a new idea: Creating even more deadly mosquitos to fight back.
July 21- European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit. The European Medicines Agency said its committee of experts refused authorisation to market the investigational drug, Onzeald, as a first-line treatment for adults with advanced...
LONDON, July 21- AstraZeneca Chief Executive Pascal Soriot, responding to rumours he might leave the drugmaker to join rival Teva Pharmaceutical Industries, has told staff he expects to work together with employees to see the company succeed. A company spokeswoman added he was intending to attend the European Society for Medical Oncology annual meeting in...
Obamacare won't collapse under its own weight — if it is done in, it will be because of Republicans, Mario Molina said.
As bad headlines fade and Vertex rises, biotechnology is on the upswing, says Jefferies' Michael Yee.
McConnell said Senate vote on a motion next week to move ahead with a bill to repeal and or replace Obamacare could easily be amended.
Dr. Fares Haddad, orthopedic surgeon, is the first surgeon in the United Kingdom to use robots in surgery and discusses the future of robots in medicine.
Chipotle says a Virginia store that was temporarily closed because of a suspected case of norovirus will reopen Wednesday.
The ongoing battle for Charlie Gard's treatment has taken a new turn.
Vic Gundotra, Alive Cor CEO, discusses his company's partnership with the Mayo Clinic for its heart monitoring device as well as the future for technology in health care and the wearables market.
July 18- Safeway Inc has agreed to pay $3 million to resolve claims the U.S. supermarket chain failed to promptly report missing or stolen drugs including opioid medications at its pharmacies, the U.S. Justice Department said on Tuesday. Albertsons, one of the largest U.S. grocery chains, is backed by private equity firm Cerberus Capital Management LP.
July 18- Vertex Pharmaceuticals Inc said on Tuesday three different triple combinations of cystic fibrosis treatments significantly improved patient lung function in clinical trials, bolstering its goal of a therapy that could help up to 90 percent of patients with the life-shortening lung disease. The company's shares jumped 24 percent to $164 after the...
July 18- Vertex Pharmaceuticals Inc on Tuesday said three different triple combinations of cystic fibrosis treatments significantly improved patient lung function in clinical trials, bolstering its goal of a therapy that could help up to 90 percent of patients with the life-shortening lung disease. Once it has analyzed additional data and discussed...
CNBC's Meg Tirrell reports on a jump in shares of Puma after the FDA approves a drug for breast cancer and the projected costs of the drug.
July 18- Gilead Sciences Inc said on Tuesday that the U.S. Food and Drug Administration approved its hepatitis C drug for patients who had failed to respond to prior treatments. Vosevi is the first drug to be approved for hepatitis C patients already treated with Sovaldi or other drugs, which inhibit a protein called NS5A, the FDA said in a separate release.
NASHVILLE, Tenn.— Pharmacies in Tennessee are accusing the state of breaking federal law and endangering people with bleeding disorders such as hemophilia by reducing reimbursements for prescription blood-clotting drugs through its Medicaid program. Hemophilia is very rare, affecting about 20,000 people in the United States, according to the federal...
July 17- The U.S. Food and Drug Administration on Monday approved Puma Biotechnology Inc's experimental breast cancer drug that lowers the risk of the disease returning after initial treatment. The stock has so far more than doubled in value since May when the FDA said in a preliminary review that Puma Biotech's drug, neratinib, appeared to be effective.
July 17- The U.S. Food and Drug Administration on Monday approved Puma Biotechnology Inc's experimental breast cancer drug that lowers the risk of the disease returning after initial treatment. Puma Biotech's drug the first treatment of its kind is designed to treat early-stage breast cancer in patients with the HER2 genetic mutation whose tumor has been...
July 17- The U.S. Food and Drug Administration on Monday approved Puma Biotechnology Inc's lead drug to treat patients with a type of early-stage breast cancer.
Generic drug makers will have to wait longer after a U.S. appeals court ruled that a patent on Takeda Pharmaceutical's cancer drug Velcade is valid.